BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
26 hedge funds and large institutions have $4.65M invested in BRAINSTORM CELL THERAPUTC in 2017 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 3 closing their positions.
Holders
26
Holders Change
-1
Holders Change %
-3.7%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
9
Reduced
4
Closed
3
Calls
$335K
Puts
$8K
Net Calls
+$327K
Net Calls Change
+$317K
Top Buyers
1 |
1
BlackRock
New York
|
$327K |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$2.72M |
3 |
3
Citadel Advisors
Miami,
Florida
|
$74K |
4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$311K |
5 |
5
Northern Trust
Chicago,
Illinois
|
$145K |